Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;14(2):137–147. doi: 10.1111/j.1750-3639.2004.tb00046.x

Early‐onset Dementia with Lewy Bodies

Masaki Takao 1,2, Bernardino Ghetti 1,✉, Hirotaka Yoshida 3, Pedro Piccardo 1, Yolanda Narain 4, Jill R Murrell 1, Ruben Vidal 1, Bradley S Glazier 1, Ross Jakes 3, Miho Tsutsui 4, Maria Grazia Spillantini 4, R Anthony Crowther 3, Michel Goedert 3, Atsuo Koto 2,5
PMCID: PMC8095855  PMID: 15193026

Abstract

The clinical and neuropathological characteristics of an atypical form of dementia with Lewy bodies (DLB) are described. The proband experienced difficulties in her school performance at 13 years of age. Neurological examination revealed cognitive dysfunction, dysarthria, parkinsonism and myoclonus. By age 14 years, the symptoms had worsened markedly and the proband died at age 15 years. On neuropathological examination, the brain was severely atrophic. Numerous intracytoplasmic and intraneuritic Lewy bodies, as well as Lewy neurites, were present throughout the cerebral cortex and subcortical nuclei; vacuolar changes were seen in the upper layers of the neocortex and severe neuronal loss and gliosis were evident in the cerebral cortex and substantia nigra. Lewy bodies and Lewy neurites were strongly immunoreactive for α‐synuclein and ubiquitin. Lewy bodies were composed of filamentous and granular material and isolated filaments were decorated by α‐synuclein antibodies. Immunohistochemistry for tau or β‐amyloid yielded negative results. The etiology of this atypical form of DLB is unknown, since there was no family history and since sequencing of the exonic regions of α‐Synuclein, β‐Synuclein, Synphilin‐1, Parkin, Ubiquitin C‐terminal hydrolase L1 and Neurofilament‐M failed to reveal a pathogenic mutation. This study provides further evidence of the clinical and pathological heterogeneity of DLB.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

REFERENCES

  • 1. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MCJ, Squiteri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ‐1 gene associated with autosomal recessive early‐onset parkinsonism. Science 299:256–259. [DOI] [PubMed] [Google Scholar]
  • 2. Campbell BCV, Li QL, Culvenor JG, Jäkälä P, Cappai R, Beyreuther K, Masters CL, McLean CA (2000) Accumulation of insoluble α‐synuclein in dementia with Lewy bodies. Neurobiol Dis 7: 192–200. [DOI] [PubMed] [Google Scholar]
  • 3. Carmel G, Mager EM, Binder LI, Kuret J (1996) The structural basis of monoclonal antibody Alz50s selectivity for Alzheimer's disease pathology. J Biol Chem 271:32789–32795. [DOI] [PubMed] [Google Scholar]
  • 4. Chen R, Gosavi NS, Langston JW, Chan P (2003) Parkin mutations are rare in patients with young‐onset parkinsonism in a US population. Parkinsonism Rel Disord 9:309–312. [DOI] [PubMed] [Google Scholar]
  • 5. Crowther RA (1991) Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci USA 88:2288–2292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Crowther RA, Daniel SE, Goedert M (2000) Characterisation of isolated α‐synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci Lett 292:128–130. [DOI] [PubMed] [Google Scholar]
  • 7. Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, Sonderegger P, Kinter J, Becker LM, Lacbawan F, Krasnewich D, Muenke M, Lawrence DA, Yerby MS, Shaw CM, Gooptu B, Elliott PR, Finch JT, Carrell RW, Lomas DA (1999) Familial dementia caused by polymerization of mutant neuroserpin. Nature 401:376–379. [DOI] [PubMed] [Google Scholar]
  • 8. Der‐Sarkissian A, Jao CC, Chen J, Langen R (2003) Structural organization of α‐synuclein fibrils by site‐directed spin labeling. J Biol Chem 278:37530–37535. [DOI] [PubMed] [Google Scholar]
  • 9. Duda JE, Giasson BI, Mabon ME, Lee VMY, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210. [DOI] [PubMed] [Google Scholar]
  • 10. Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn‐Hardy K, Petrucelli L, Hussey J, Singleton A, Tanner C, Hardy J, Langston JW (2001) Lewy bodies and parkinsonism in families with parkin mutations. Neurology 50: 293–300. [DOI] [PubMed] [Google Scholar]
  • 11. Farrer M, Destée A, Levesque C, Singleton A, Engelender S, Becquet E, Mouroux V, Richard F, Defebre L, Crook R, Hernandez D, Ross CA, Hardy J, Amouyel P, Chartier‐Harlin MC (2001) Genetic analysis of synphilin‐1 in familial Parkinson's disease. Neurobiol Dis 8:317–323. [DOI] [PubMed] [Google Scholar]
  • 12. Fenichel GM, Bazeloa M (1968) Studies on neuromelanin. II. Melanin in the brainstems of infants and children. Neurology 18:18:817–820. [DOI] [PubMed] [Google Scholar]
  • 13. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259–272. [DOI] [PubMed] [Google Scholar]
  • 14. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) α‐Synuclein is phosphorylated in synucleinopathy lesions. Nature Cell Biol 4:160–164. [DOI] [PubMed] [Google Scholar]
  • 15. Gasser T, Müller‐Myhsok B, Wszolek ZK, Oehlmann R, Calner DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nature Genet 18:262–265. [DOI] [PubMed] [Google Scholar]
  • 16. Giasson BI, Jakes R, Goedert M, Duda JE, Leight S, Trojanowski JQ, Lee VMY (2000) A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in Lewy bodies of Parkinson's disease. J Neurosci Res 59:528–533. [DOI] [PubMed] [Google Scholar]
  • 17. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VMY (2003) Initiation and synergistic fibrillization of tau and alpha‐synuclein. Science 300:636–640. [DOI] [PubMed] [Google Scholar]
  • 18. Gibb WRG, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131–1153. [DOI] [PubMed] [Google Scholar]
  • 19. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule‐associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519–526. [DOI] [PubMed] [Google Scholar]
  • 20. Goedert M (2001) Alpha‐synuclein and neurodegenerative diseases. Nature Rev Neurosci 2: 492–501. [DOI] [PubMed] [Google Scholar]
  • 21. Goldman JE, Yen SH, Chiu FC, Peress NS (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–1084. [DOI] [PubMed] [Google Scholar]
  • 22. Gwinn‐Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Yen SH, Hardy J, Dickson DW (2000) Distinctive neuropathology revealed by α‐synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 99:663–672. [DOI] [PubMed] [Google Scholar]
  • 23. Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VMY, Trojanowski JQ, Mann D, Iwatsubo T (2002) Phosphorylated α‐synuclein is ubiquitinated in α‐synucleinopathy lesions. J Biol Chem 277, 49071–49076. [DOI] [PubMed] [Google Scholar]
  • 24. Hayashi S, Wakabayashi K, Ishikawa A, Nagai H, Saito M, Maruyama M, Takahashi T, Ozawa T, Tsuji S, Takahashi H (2000) An autopsy case of autosomal‐recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15:884–888. [DOI] [PubMed] [Google Scholar]
  • 25. Huynh DP, Scoles DR, Ho TH, Del Bigio MR, Pulst SM (2000) Parkin is associated with actin filaments in neuronal and nonneuronal cells. Ann Neurol 48:737–744. [PubMed] [Google Scholar]
  • 26. Ince PG, McKeith IG (2003) Dementia with Lewy bodies. In: Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (Dickson D., ed), pp. 188–199. ISN Neuropath Press, Basel 2003. [Google Scholar]
  • 27. Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K (1999) Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 19:386–394. [Google Scholar]
  • 28. Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha‐synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62:389–399. [DOI] [PubMed] [Google Scholar]
  • 29. Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345:27–32. [DOI] [PubMed] [Google Scholar]
  • 30. Jakes R, Crowther RA, Lee VMY, Trojanowski JQ, Iwatsubo T, Goedert M (1999) Epitope mapping of LB509, a monoclonal antibody directed against human α‐synuclein. Neurosci Lett 269: 13–16. [DOI] [PubMed] [Google Scholar]
  • 31. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605–608. [DOI] [PubMed] [Google Scholar]
  • 32. Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237:197–204. [DOI] [PubMed] [Google Scholar]
  • 33. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O (1998) Ala30Pro mutation in the gene encoding α‐synuclein in Parkinson's disease. Nature Genet 18:106–108. [DOI] [PubMed] [Google Scholar]
  • 34. Lavedan C, Leroy E, Torres R, Dehejia A, Dutra A, Buchholtz S, Nussbaum RL, Polymeropoulos MH (1998) Genomic organization and expression of the human α‐synuclein gene (SNCB). Genomics 54:173–175. [DOI] [PubMed] [Google Scholar]
  • 35. Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH (2002) A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci Lett 322:57–61. [DOI] [PubMed] [Google Scholar]
  • 36. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson's disease. Nature 395:451–452. [DOI] [PubMed] [Google Scholar]
  • 37. McQuaid S, McConnell R, McMahon J, Herron B (1995) Microwave antigen retrieval for immunocytochemistry on formalin‐fixed, paraffin‐embedded post‐mortem CNS tissue. J Pathol 176:207–216. [DOI] [PubMed] [Google Scholar]
  • 38. Miake H, Mizusawa H, Iwatsubo H, Hasegawa M (2002) Biochemical characterization of the core structure of α‐synuclein filaments. J Biol Chem 277:19213–19219. [DOI] [PubMed] [Google Scholar]
  • 39. Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa‐Hattori Y, Miyake T, Suda, K , Mizuno Y (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 51:890–892. [DOI] [PubMed] [Google Scholar]
  • 40. Morimatsu Y, Satoh J, Nagata J, Kubota Y, Hayashi M, Sakamoto K, Shinohara T (1987) Pathology of neuromelanin in the development disabilities. Kouseishour Shinkei Shikkan Kenkyu Itaku Jigyou (Japanese) 1:268–282. [Google Scholar]
  • 41. Murray IVJ, Medford MA, Guan HP, Rueter SM, Trojanowski JQ, Lee VMY (2003) Synphilin in normal human brain and in synucleinopathies: studies with new antibodies. Acta Neuropathol 105:177–184. [DOI] [PubMed] [Google Scholar]
  • 42. Ozawa T, Takano H, Onodera O, Kobayashi H, Ikeuchi T, Koide R, Okuizumi K, Shimohata T, Wakabayashi K, Takahashi H, Tsuji T (1999) No mutation in the entire coding region of the α‐synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 270:110–112. [DOI] [PubMed] [Google Scholar]
  • 43. Piccardo P, Mirra SS, Young K, Gearing M, Dlouhy SR, Ghetti B (1998) α‐Synuclein accumulation in Gerstmann‐Sträussler‐Scheinker disease (GSS) with prion protein gene mutation F 198S. Neurobiol Aging 19:S 172. [Google Scholar]
  • 44. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubinstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α‐synuclein gene identified in families with Parkinson's disease. Science 276:2045–2047. [DOI] [PubMed] [Google Scholar]
  • 45. Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, Lee VMY (2003) Ubiquitination of α‐synuclein is not required for formation of pathological inclusions in α‐synucleinopathies. Am J Pathol 163:91–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160: 1655–1667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn‐Hardy K (2003) α‐Synuclein locus triplication causes Parkinson's disease. Science 302:841. [DOI] [PubMed] [Google Scholar]
  • 48. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) α‐Synuclein in Lewy bodies. Nature 388, 839–840. [DOI] [PubMed] [Google Scholar]
  • 49. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α‐Synuclein in filamentous inclusions of Lewy bodies from Parkinson disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F (1994) Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44:437–441. [DOI] [PubMed] [Google Scholar]
  • 51. Takao M, Benson MD, Murrell JR, Yazaki M, Piccardo P, Unverzagt FW, Davis RL, Holohan PD, Lawrence DA, Richardson R, Farlow MR, Ghetti B (2000) Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy. J. Neuropathol Exp Neurol 59:1070–1078. [DOI] [PubMed] [Google Scholar]
  • 52. Tofaris GK, Razzaq A, Ghetti B, Lilley K, Spillantini MG (2003) Ubiquitination of α‐synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278:44405–44411. [DOI] [PubMed] [Google Scholar]
  • 53. Van de Warrenburg BPC, Lammens M, Lücking CB, Denefle P, Wesseling P, Booij J, Praamstra P, Quinn N, Brice A, Horstink MWIM (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 56:555–557. [DOI] [PubMed] [Google Scholar]
  • 54. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H (2000) Synphilin‐1 is present in Lewy bodies in Parkinson's disease. Acta Neuropathol 47:521–523. [PubMed] [Google Scholar]
  • 55. West A, Périquet M, Lincoln S, Lücking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, Maraganore D, Levey A, Wood N, Dürr A, Hardy J, Brice A, Farrer M (2002) Complex relationship between parkin mutations and Parkinson's disease. Am J Med Genet 114:584–591. [DOI] [PubMed] [Google Scholar]
  • 56. Wintermeyer P, Krüger R, Kuhn W, Müller T, Woitalla D, Berg D, Becker G, Leroy E, Polymeropoulos M, Berger K, Przuntek H, Schöls L, Epplen JT, Riess O (2000) Mutation analysis and association studies of the UCHL 1 gene in German Parkinson's disease patients. Neuroreport 11: 2079–2082. [DOI] [PubMed] [Google Scholar]
  • 57. Wzolek ZK, Gwinn‐Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW (2002) Neuropathology of two members of a German‐American kindred (Family C) with late onset parkinsonism. Acta Neuropathol 103:344–350. [DOI] [PubMed] [Google Scholar]
  • 58. Yoshimura N, Yoshimura I, Asada M, Hayashi S, Fukushima Y, Sato T, Kudo H (1988) Juvenile Parkinson's disease with widespread Lewy bodies in the brain. Acta Neuropathol 77:213–218. [DOI] [PubMed] [Google Scholar]
  • 59. Zarranz JJ, Alegre J, Gomez‐Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha‐synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES